These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8111384)

  • 1. Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome.
    Aoyama T; Tynan K; Dietz HC; Francke U; Furthmayr H
    Hum Mol Genet; 1993 Dec; 2(12):2135-40. PubMed ID: 8111384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes.
    Schrijver I; Liu W; Brenn T; Furthmayr H; Francke U
    Am J Hum Genet; 1999 Oct; 65(4):1007-20. PubMed ID: 10486319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome.
    Milewicz DM; Grossfield J; Cao SN; Kielty C; Covitz W; Jewett T
    J Clin Invest; 1995 May; 95(5):2373-8. PubMed ID: 7738200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains.
    Dietz HC; Saraiva JM; Pyeritz RE; Cutting GR; Francomano CA
    Hum Mutat; 1992; 1(5):366-74. PubMed ID: 1301946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels.
    Zeyer KA; Reinhardt DP
    Mutat Res Rev Mutat Res; 2015; 765():7-18. PubMed ID: 26281765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders.
    Whiteman P; Handford PA
    Hum Mol Genet; 2003 Apr; 12(7):727-37. PubMed ID: 12651868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillin secretion and microfibril assembly by Marfan dermal fibroblasts.
    Kielty CM; Phillips JE; Child AH; Pope FM; Shuttleworth CA
    Matrix Biol; 1994 Mar; 14(2):191-9. PubMed ID: 8061930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein.
    Glanville RW; Qian RQ; McClure DW; Maslen CL
    J Biol Chem; 1994 Oct; 269(43):26630-4. PubMed ID: 7929395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms.
    Aoyama T; Francke U; Dietz HC; Furthmayr H
    J Clin Invest; 1994 Jul; 94(1):130-7. PubMed ID: 8040255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12-13 region of fibrillin-1.
    Whiteman P; Willis AC; Warner A; Brown J; Redfield C; Handford PA
    Hum Mol Genet; 2007 Apr; 16(8):907-18. PubMed ID: 17324963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome.
    Dietz HC; McIntosh I; Sakai LY; Corson GM; Chalberg SC; Pyeritz RE; Francomano CA
    Genomics; 1993 Aug; 17(2):468-75. PubMed ID: 8406497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome.
    Liu W; Qian C; Comeau K; Brenn T; Furthmayr H; Francke U
    Hum Mol Genet; 1996 Oct; 5(10):1581-7. PubMed ID: 8894692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal fibrillin assembly by dermal fibroblasts from two patients with Marfan syndrome.
    Kielty CM; Shuttleworth CA
    J Cell Biol; 1994 Mar; 124(6):997-1004. PubMed ID: 8132720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated profibrillin of a Marfan patient is of apparent similar size as fibrillin: intracellular retention leads to over-N-glycosylation.
    Raghunath M; Kielty CM; Steinmann B
    J Mol Biol; 1995 May; 248(5):901-9. PubMed ID: 7760331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly.
    Putnam EA; Zhang H; Ramirez F; Milewicz DM
    Nat Genet; 1995 Dec; 11(4):456-8. PubMed ID: 7493032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of eight mutations in FBN1.
    Halliday D; Hutchinson S; Kettle S; Firth H; Wordsworth P; Handford PA
    Hum Genet; 1999 Dec; 105(6):587-97. PubMed ID: 10647894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.
    Dietz HC; Pyeritz RE
    Hum Mol Genet; 1995; 4 Spec No():1799-809. PubMed ID: 8541880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts.
    Milewicz DM; Pyeritz RE; Crawford ES; Byers PH
    J Clin Invest; 1992 Jan; 89(1):79-86. PubMed ID: 1729284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillin domain folding and calcium binding: significance to Marfan syndrome.
    Wu YS; Bevilacqua VL; Berg JM
    Chem Biol; 1995 Feb; 2(2):91-7. PubMed ID: 9383409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine-to-arginine point mutation in a 'hybrid' eight-cysteine domain of FBN1: consequences for fibrillin aggregation and microfibril assembly.
    Kielty CM; Rantamäki T; Child AH; Shuttleworth CA; Peltonen L
    J Cell Sci; 1995 Mar; 108 ( Pt 3)():1317-23. PubMed ID: 7622614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.